2019
Tobacco‐21 laws and young adult smoking: quasi‐experimental evidence
Friedman AS, Buckell J, Sindelar JL. Tobacco‐21 laws and young adult smoking: quasi‐experimental evidence. Addiction 2019, 114: 1816-1823. PMID: 31342591, PMCID: PMC7233410, DOI: 10.1111/add.14653.Peer-Reviewed Original ResearchThe impact of flavors, health risks, secondhand smoke and prices on young adults’ cigarette and e‐cigarette choices: a discrete choice experiment
Buckell J, Sindelar JL. The impact of flavors, health risks, secondhand smoke and prices on young adults’ cigarette and e‐cigarette choices: a discrete choice experiment. Addiction 2019, 114: 1427-1435. PMID: 30866132, PMCID: PMC6639008, DOI: 10.1111/add.14610.Peer-Reviewed Original ResearchConceptsE-cigarettesHealth harmsYoung adultsSmoking groupNational Health Interview SurveySecondhand smoke risksHealth Interview SurveyShort-term health risksHealth risksSecondhand smokeSmoking typesYoung adults' preferencesDiscrete choice experimentCigarettesInterview SurveySmoke risksAdultsOnline discrete choice experimentCensus regionRiskCigarette pricesImpact of flavourCandy flavorsGroupHealthPatterns of Youth Cigarette Experimentation and Onset of Habitual Smoking
Friedman AS, Buckell J, Sindelar JL. Patterns of Youth Cigarette Experimentation and Onset of Habitual Smoking. American Journal Of Preventive Medicine 2019, 56: 803-810. PMID: 31005466, PMCID: PMC6594175, DOI: 10.1016/j.amepre.2019.02.009.Peer-Reviewed Original Research
2016
Exploring Explanations for the Female-Male Earnings Difference Among Registered Nurses in the United States.
Muench U, Busch SH, Sindelar J, Buerhaus PI. Exploring Explanations for the Female-Male Earnings Difference Among Registered Nurses in the United States. Nursing Economics 2016, 34: 214-23. PMID: 29975036.Peer-Reviewed Original Research
2015
Salary Differences Between Male and Female Registered Nurses in the United States
Muench U, Sindelar J, Busch SH, Buerhaus PI. Salary Differences Between Male and Female Registered Nurses in the United States. JAMA 2015, 313: 1265-1267. PMID: 25803350, DOI: 10.1001/jama.2015.1487.Peer-Reviewed Original Research
2012
Smoke-free policies in drinking venues predict transitions in alcohol use disorders in a longitudinal U.S. sample
Young-Wolff KC, Hyland AJ, Desai R, Sindelar J, Pilver CE, McKee SA. Smoke-free policies in drinking venues predict transitions in alcohol use disorders in a longitudinal U.S. sample. Drug And Alcohol Dependence 2012, 128: 214-221. PMID: 22999418, PMCID: PMC4052952, DOI: 10.1016/j.drugalcdep.2012.08.028.Peer-Reviewed Original ResearchConceptsAlcohol use disorderSmoke-free legislationSmoke-free policiesAUD remissionUse disordersLikelihood of AUDWave IIndoor public venuesLongitudinal U.S. sampleTobacco-related diseasesYounger age groupsNational Epidemiological SurveySmoke-free barsPublic health benefitsAUD onsetHigh comorbidityProtective effectCurrent drinkersTobacco useEpidemiological surveyAge groupsLogistic regressionRelated conditionsHeavy drinkingLower likelihood
2011
UNDERSTANDING HETEROGENEITY IN PRICE ELASTICITIES IN THE DEMAND FOR ALCOHOL FOR OLDER INDIVIDUALS
Ayyagari P, Deb P, Fletcher J, Gallo W, Sindelar JL. UNDERSTANDING HETEROGENEITY IN PRICE ELASTICITIES IN THE DEMAND FOR ALCOHOL FOR OLDER INDIVIDUALS. Health Economics 2011, 22: 89-105. PMID: 22162113, PMCID: PMC3641566, DOI: 10.1002/hec.1817.Peer-Reviewed Original ResearchConceptsPrice elasticityRetirement Study dataDeadweight lossHigher taxPrice responsivenessNegative externalitiesUnobserved heterogeneityPolicy implicationsFinancial resourcesExternalitiesPricesFinite mixture modelDisadvantaged groupsElasticityLatent groupsDemandTaxGreater responsivenessOlder IndividualsStudy dataHeterogeneityImplicationsResourcesThe effect of job loss on overweight and drinking
Deb P, Gallo WT, Ayyagari P, Fletcher JM, Sindelar JL. The effect of job loss on overweight and drinking. Journal Of Health Economics 2011, 30: 317-327. PMID: 21288586, PMCID: PMC3086369, DOI: 10.1016/j.jhealeco.2010.12.009.Peer-Reviewed Original Research
2010
Differential changes in body mass index after retirement by occupation: hierarchical models
Gueorguieva R, Sindelar JL, Wu R, Gallo WT. Differential changes in body mass index after retirement by occupation: hierarchical models. International Journal Of Public Health 2010, 56: 111-116. PMID: 20625792, PMCID: PMC3154720, DOI: 10.1007/s00038-010-0166-z.Peer-Reviewed Original ResearchConceptsBMI trajectoriesBody mass indexBody mass index (BMI) patternsMass indexHealth habitsBlue-collar occupationsOlder individualsJob physical demandsOccupational classBlue-collar workersNational dataSignificant increaseDifferential changesWhite-collar occupationsPhysical demandsCollar workersSocioeconomic characteristics
2009
Work expectations, realizations, and depression in older workers.
Falba TA, Sindelar JL, Gallo WT. Work expectations, realizations, and depression in older workers. The Journal Of Mental Health Policy And Economics 2009, 12: 175-86. PMID: 20195005, PMCID: PMC3434685.Peer-Reviewed Original ResearchThe Impact of Occupation on Self-Rated Health: Cross-Sectional and Longitudinal Evidence from the Health and Retirement Survey
Gueorguieva R, Sindelar JL, Falba TA, Fletcher JM, Keenan P, Wu R, Gallo WT. The Impact of Occupation on Self-Rated Health: Cross-Sectional and Longitudinal Evidence from the Health and Retirement Survey. The Journals Of Gerontology Series B 2009, 64B: 118-124. PMID: 19196689, PMCID: PMC2654983, DOI: 10.1093/geronb/gbn006.Peer-Reviewed Original ResearchConceptsSelf-reported healthOlder individualsSelf-reported health statusSignificant baseline differencesSelf-rated healthHealth habitsBaseline differencesOccupation-related differencesHealth statusHealth trajectoriesImpact of occupationKey covariatesStudy sampleSignificant differencesRetirement StudyHealthOccupational categoriesRetirement SurveyLongitudinal evidenceIndividual ageOccupational differencesIndividualsDifferences
2008
Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients
Jones ES, Moore BA, Sindelar JL, O’Connor P, Schottenfeld RS, Fiellin DA. Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients. Drug And Alcohol Dependence 2008, 99: 132-140. PMID: 18804923, PMCID: PMC2646001, DOI: 10.1016/j.drugalcdep.2008.07.013.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBuprenorphineCohort StudiesCost of IllnessCosts and Cost AnalysisData Interpretation, StatisticalFemaleHealth PersonnelHumansMaleMethadoneMiddle AgedNarcoticsOpioid-Related DisordersPhysicians' OfficesSocioeconomic FactorsSubstance Abuse DetectionSubstance Abuse Treatment CentersTreatment OutcomeYoung AdultConceptsOffice-based treatmentOpioid dependencePatient costsClinical contactMonthly medication costsOffice-based buprenorphineOffice-based methadoneMonths of treatmentAnalysis of treatmentTotal monthly costsChi-square testMonths of maintenanceStable patientsMedication costsPatientsMethadoneMonthly costBuprenorphineTreatmentMonthsStatistical comparisonCost estimatesClinic
2007
Willingness to pay for drug rehabilitation: Implications for cost recovery
Bishai D, Sindelar J, Ricketts EP, Huettner S, Cornelius L, Lloyd JJ, Havens JR, Latkin CA, Strathdee SA. Willingness to pay for drug rehabilitation: Implications for cost recovery. Journal Of Health Economics 2007, 27: 959-972. PMID: 18207264, PMCID: PMC2601723, DOI: 10.1016/j.jhealeco.2007.11.007.Peer-Reviewed Original ResearchCost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease
Rosenheck RA, Leslie DL, Sindelar JL, Miller EA, Tariot PN, Dagerman KS, Davis SM, Lebowitz BD, Rabins P, Hsiao JK, Lieberman JA, Schneider LS. Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease. JAMA Psychiatry 2007, 64: 1259-1268. PMID: 17984395, DOI: 10.1001/archpsyc.64.11.1259.Peer-Reviewed Original ResearchConceptsCost-benefit analysisSecond-generation antipsychoticsGreatest net health benefitNet benefit analysisNet health benefitWholesale priceHealth Utilities Index Mark 3Economic perspectiveAlzheimer's diseaseBenefit approachHealth care costsTotal health costsHealth costsQALYsCare costsMeasures of effectivenessPlacebo-controlled trialLower health care costsHealth service useTotal health careMeasures of functionCostTreatment of psychosisQuality of lifeSensitivity analysisCost‐effectiveness of prize‐based contingency management in methadone maintenance treatment programs
Sindelar JL, Olmstead TA, Peirce JM. Cost‐effectiveness of prize‐based contingency management in methadone maintenance treatment programs. Addiction 2007, 102: 1463-1471. PMID: 17645428, PMCID: PMC3072844, DOI: 10.1111/j.1360-0443.2007.01913.x.Peer-Reviewed Original ResearchConceptsPrize-based contingency managementUsual careContingency managementStimulant-negative urine samplesUrine samplesNational Drug Abuse Treatment Clinical Trials NetworkTreatment programMethadone maintenance treatment programIncremental costBaseline urine samplesMulti-site clinical trialMaintenance treatment programMethadone maintenance clinicsClinical Trials NetworkCommunity treatment programsCost-effectiveness studiesCost of treatmentCost-effectiveness analysisPresence of stimulantsCM conditionClinical trialsCommunity clinicsMaintenance clinicsEffectiveness trialTreatment outcomesThe cost‐effectiveness of four treatments for marijuana dependence
Olmstead TA, Sindelar JL, Easton CJ, Carroll KM. The cost‐effectiveness of four treatments for marijuana dependence. Addiction 2007, 102: 1443-1453. PMID: 17645430, PMCID: PMC2398724, DOI: 10.1111/j.1360-0443.2007.01909.x.Peer-Reviewed Original ResearchConceptsMET/CBTDrug counselingContingency managementPatient outcomesYoung adultsEffective treatmentMarijuana dependenceAcceptability curvesIncremental cost-effectiveness ratioRandomized clinical trialsCost of therapyPatient outcome measuresCost-effective dependsCost-effectiveness ratioSubstance abuse clinicsCost-effective treatmentCM procedureClinical trialsOutcome measuresUrine specimenUrine specimensAdditional weeksAdditional studiesMarijuana abstinenceLonger durationSpousal Concordance in Health Behavior Change
Falba TA, Sindelar JL. Spousal Concordance in Health Behavior Change. Health Services Research 2007, 43: 96-116. PMID: 18211520, PMCID: PMC2323137, DOI: 10.1111/j.1475-6773.2007.00754.x.Peer-Reviewed Original ResearchConceptsHealth habitsHealth behaviorsPreventive medical careHealth behavior changeCholesterol screeningFlu shotPreventive servicesMedical careSpousal concordanceAnalytic sampleRetirement StudyHRS surveyBehavior changeRepresentative sampleSpousesHabitsSpouse behaviorDisease diagnosisIndividualsLongitudinal dataSmokingDiagnosisPersonsCareDirect Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and Beliefs
McCarty D, Fuller BE, Arfken C, Miller M, Nunes EV, Edmundson E, Copersino M, Floyd A, Forman R, Laws R, Magruder KM, Oyama M, Prather K, Sindelar J, Wendt WW. Direct Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and Beliefs. Psychiatric Services 2007, 58: 181-190. PMID: 17287373, PMCID: PMC2861362, DOI: 10.1176/ps.2007.58.2.181.Peer-Reviewed Original ResearchAdultAge FactorsAlcoholismAttitude of Health PersonnelBehavior TherapyClinical Trials as TopicCognitive Behavioral TherapyCultureData CollectionDiffusion of InnovationEducational StatusEthnicityEvidence-Based MedicineFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPatient Care TeamProfessional CompetenceProfessional-Patient RelationsPsychotropic DrugsSex FactorsSocioeconomic FactorsSubstance Abuse Treatment CentersSubstance-Related DisordersUnited StatesWhat do we get for our money? Cost‐effectiveness of adding contingency management
Sindelar J, Elbel B, Petry NM. What do we get for our money? Cost‐effectiveness of adding contingency management. Addiction 2007, 102: 309-316. PMID: 17222286, DOI: 10.1111/j.1360-0443.2006.01689.x.Peer-Reviewed Original Research
2006
Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs
Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug And Alcohol Dependence 2006, 87: 175-182. PMID: 16971054, PMCID: PMC1950254, DOI: 10.1016/j.drugalcdep.2006.08.012.Peer-Reviewed Original ResearchConceptsUsual careStimulant abusersClinical trialsPatient outcomesNational Drug Abuse Treatment Clinical Trials NetworkDrug abuse treatment clinicsAbstinence-based incentivesIncremental cost-effectiveness ratioUsual care groupPrimary patient outcomeRandomized clinical trialsClinical Trials NetworkPsychosocial treatment programCost-effectiveness ratioCost-effectiveness analysisCare groupTreatment clinicsStimulant abstinenceAcceptability curvesAbstinence timeTreatment programTrials NetworkIncremental costCareIncentive group